Similar to MLL-AF9-induced AML, the onset of RUNX1-ETO9a-induced AML was delayed in Rag2−/− mice compared to WT mice, and it became more evident with the treatment with DS-5272 (Fig. 5a). The gene discussed is RAG2; the disease is acute myeloid leukemia.